Does PEMBROLIZUMAB Cause Dermatitis exfoliative? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Dermatitis exfoliative have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.0% of all adverse event reports for PEMBROLIZUMAB.
17
Reports of Dermatitis exfoliative with PEMBROLIZUMAB
0.0%
of all PEMBROLIZUMAB reports
7
Deaths
13
Hospitalizations
How Dangerous Is Dermatitis exfoliative From PEMBROLIZUMAB?
Of the 17 reports, 7 (41.2%) resulted in death, 13 (76.5%) required hospitalization, and 1 (5.9%) were considered life-threatening.
Is Dermatitis exfoliative Listed in the Official Label?
Yes, Dermatitis exfoliative is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Dermatitis exfoliative?
CIPROFLOXACIN (91)
ALLOPURINOL (86)
SULFAMETHOXAZOLE\TRIMETHOPRIM (75)
CLOPIDOGREL BISULFATE (73)
FUROSEMIDE (73)
ATORVASTATIN (71)
AMLODIPINE (70)
ACETAMINOPHEN (66)
VANCOMYCIN (66)
SIMVASTATIN (64)
Which PEMBROLIZUMAB Alternatives Have Lower Dermatitis exfoliative Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G